bicalutamide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
COSAMIDE 50 bicalutamide 50mg film-coated tablet blister pack
AUST R: 162829
Active ingredients:
bicalutamide

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
01 Aug 2025
to
14 Sep 2025

Shortage status:
Anticipated

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
Alternative generic products are available.

APO-BICALUTAMIDE bicalutamide 50mg film-coated tablet blister pack
AUST R: 194683
Active ingredients:
bicalutamide

Dosage form:
Tablet, film coated

Sponsor:
Arrotex Pharmaceuticals Pty Ltd

Phone:
1800 195 055

From
03 Jan 2025
to
05 Jun 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

BI ELIGARD CP (Eligard 1 month 7.5mg and MPL-Bicalutamide 50mg, 28 pack)
AUST R: 237653
Active ingredients:
leuprorelin acetate
bicalutamide

Dosage form:
Injection, modified release

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

Deletion from market:
14 Oct 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available.

BI ELIGARD CP (Eligard 3 month 22.5mg and MPL-Bicalutamide 50mg, 28 pack)
AUST R: 238311
Active ingredients:
leuprorelin acetate
bicalutamide

Dosage form:
Injection, modified release

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

Deletion from market:
11 Jun 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available.

BI ELIGARD CP (Eligard 3 month 22.5mg and MPL-Bicalutamide 50mg, 84 pack)
AUST R: 237652
Active ingredients:
leuprorelin acetate
bicalutamide

Dosage form:
Injection, modified release

Sponsor:
Mundipharma Pty Ltd

Phone:
1800 188 009

Deletion from market:
15 Jul 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available.

CALUTEX bicalutamide 50 mg tablets blister pack
AUST R: 135858
Active ingredients:
bicalutamide

Dosage form:
Tablet, film coated

Sponsor:
Aspen Pharma Pty Ltd

Phone:
1300659646

Deletion from market:
01 May 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.